SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (1457)6/26/1997 10:05:00 PM
From: biowa   of 9719
 
!Kung,

>> Care to provide a simple example and explain a bit more about how one arbitrarily choses a reasonable pv?<<

You should know better than to ask an academic for a simple example...by the way, I assume you mean a reasonable discount rate?

IMO, 20% is often the starting point for a company in a fairly stable industry, with reasonably predictable and current earnings. You might add 5% to that for companies that depend on risky pipelines for continued earnings growth or in a rapidly evolving industry, that have somewhat predictable and current or very near term earnings (i.e., only the most stable biotechs) for a rate of 25%. You might give companies with ongoing positive net income expected in the next year or two, a rate of 30-35%, based on a subjective judgement of several factors. Anything farther out than that may deserve a 35-40% rate. Note that VC typically expects at least a 40% return, and usually more like >50%, so you see that there is a regular trend as companies mature. This is all for example only. I probably wouldn't use exactly these numbers, and I'm sure V1 would differ from these as well, but I hope this helps.

biowa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext